Article
Pharmacogenetics of treatment with leukotriene modifiers.
Current opinion in allergy and clinical immunology - 1 Oct 2002
Wechsler Michael E, Israel Elliot
Abstract excerpt
UNLABELLED: PURPOSE OF REVIEW Pharmacogenetics is emerging as a field with great potential to improve both our understanding and treatment options in asthma. This review highlights the importance of pharmacogenetic associations of an important class of asthma therapy, the leukotriene modifiers, and asthma. RECENT FINDINGS: Over the past decade, different leukotriene modifier therapies have emerged and have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
